Cargando…
Bleeding with gastrointestinal and ureteral ulcers after gefitinib treatment: a case report
Epidermal growth factor receptor (EGFR) inhibitors, as a first-line drug treatment in the EGFR-sensitive mutation of advanced non-small-cell lung cancer (NSCLC), has been used in a wide variety of malignancies. These therapies have various troublesome side effects including diarrhea, stomatitis, muc...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798432/ https://www.ncbi.nlm.nih.gov/pubmed/35116516 http://dx.doi.org/10.21037/tcr-20-3420 |